RPG Life Sciences Limited - Regulatory Filings 2024

November 7, 2024

The Manager Listing Department National Stock Exchange of India Limited Exchange Plaza, 5th Floor Plot No. C1, 'G' Block, Bandra-Kurla Complex Bandra (East), Mumbai 400 051.

BSE Limited Corporate Relationship Department Floor 25, P.J. Towers Dalal Street Mumbai 400 001.

Symbol: RPGLIFE

Scrip code: 532983

Dear Sir/Madam,

Sub: Outcome of Board Meeting of the Company held on November 7, 2024

In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has at its meeting held on Thursday, November 7, 2024, inter-alia, considered and approved the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2024.

The said Unaudited Financial Results along with Limited Review Report of the Statutory Auditors thereon are enclosed herewith in terms of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The meeting commenced at 03:00 p.m. and concluded at 05:45 p.m.

Kindly take the above on record.

Thanking you,

Yours faithfully, For RPG Life Sciences Limited Rajesh Shirambekar Head – Legal & Company Secretary RAJESH RAMESH SHIRAMBEKAR Digitally signed by RAJESH RAMESH SHIRAMBEKAR Date: 2024.11.07 17:57:34 +05'30'

Encl: as above

12th Floor, The Ruby 29 Senapati 8apat Marg Dadar (West) Mumbai - 400 028, India

Tel : +9122 6819 8000

Independent Auditor's Review Report on the Quarterly and Year to Date Unaudited Financial Results of the Company Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended

Review Report to The Board of Directors RPG Life Sciences Limited

1. We have reviewed the accompanying statement of unaudited financial results of RPG Life Sciences Limited (the "Company") for the quarter ended September 30, 2024 and year to date from April I, 2024 to September 30, 2024 (the "Statement") attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the "Listing Regulations").
1. The Company's Management is responsible for the preparation of the Statement in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, (Ind AS 34) " Interim Financial Reporting" prescribed under Section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. The Statement has been approved by the Company's Board of Directors. Our responsibility is to express a conclusion on the Statement based on our review.
1. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, ·'Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Institute of Chartered Accountants of India. This Standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
1. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standards (' Ind AS') specified under Section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement.

For S R B C & CO LLP Chartered Accountants ICAI Firm regisfration number: 324982E/E300003

per Aruna Kumaraswamy Partner Membership No.: 219350 UDIN: 2.. 4-2. \q·)50B/:-C..'S,7-E 72. l Place: Mumbai Date: November 7, 2024

							(Rs. in Lakhs)
		Quarte r ended			Six months ended		Year ended
	Particulars	30-09-2024	30-06-2024	30-09-2023	30-09-2024	30-09-2023	31-03-2024
		Unaud ited	Unaudited	Unaudited	Unaudited	Unaudited	Audited

l	Revenue from Operations	17,22 1	16,542	15,358	33 ,763	30,136	58,205
2	Other Income	194	237	183	43 1	364	721
3	Total Incom e (1+2)	17,415	16,779	15,541	34,194	30,500	58,926
4	Expenses
	(a) Cost of Material s Consumed	2,08 1	3,237	3,730	5,3 18	6,777	12,065
	(b) Purchases of Stock-in-Trade	2,633	2,489	1,31 1	5, 122	2,977	6, 11 8
	(c) Changes in Inventories of Fini shed Goods. Work-in-Progress
	and Stock-in-Trade	703	(225)	(567)	478	(262)	270
	(ct) Employee Benefits Expense	3,309	3,274	3,359	6,583	6,638	13,2 I 5
	(e) Finance Costs	17	15	IO	32	17	45
	(f) Depreciation and Amortisation Expense	53 I	529	423	1,060	844	1,707
	(g) Other Expenses	3,902	3,860	3,796	7,762	7,053	13,722
	Total Expenses	13,176	13,179	12,062	26,355	24,044	47,142

5	Profit before exceptional items and ta x (3-4)	4,239	3,600	3,479	7,839	6,456	11 ,784
6		(2,730)			(2,730)
	Exceptional items (Refer Note 3)
7	Profit before tax	1,509	3,600	3,479	5, 109	6,456	11,784
8	Income tax expenses
	a. Current Tax	1,078	95 1	967	2,029	I ,759	3,254
	b. Deferred Tax	11	(27)	(74)	(16)	(99)	(236)
	Total tax expenses	1,089	924	893	2,013	1,660	3,018
9	Profit for the period (7-8)	420	2,676	2,586	3,096	4,796	8,766

JO	Other Comprehensive Income
	(i) Items that wi ll not be reclassified to Profit or Loss	3	2	3	5	5	(75)
	(ii) Income tax relating to items that wi ll not be reclassified to Profit or Loss
	Other Comprehensive Income Net of Tax	( I) 2	( I)	( I )	(2) 3	(2) 3	19 (56)
			I	2
11	Total Comprehensive Income for the period (9+ 10)	422	2,677	2,588	3,099	4,799	8,7 10

12	Paid-up Equity Share Capital (Face Value Rs. 8/- each)	1,323	1,323	1,323	1,323	1,323	1,323

13	Other Equity						36,162

14	Earn ings per Share (of Rs. 8/- each) (not annuali sed for the
	quarter):
	Basic (in Rs) (a)	2.54	16.18	15.64	18.72	29.00	53.0 1
	(b) Diluted (in Rs)	2.54	16.18	15.64	18.72	29.00	53 .0 1

STATEMENT OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND SIX MONTHS ENDED SEPTEMBER 30, 2024

An ~» R~G Company Af> ~

An ~»R?G Company

As at September 30,
2024	As at March 31, 2024
(Unaudited)	(Audited)

	9,703

	8,478
	1,650
	1,153
	101
	19
	43
	122
	58
	151
	21 ,478

9,9 16	10,100

9, 19 1	9,0 15
8,64 1	4,9 13
	1,972
	1,67 5
	103
	2,03 1
	29,809
	-
	51,287

	1,323
	36, 162
	37,485



29 1	303
4 15	403
706	706



	503

	6,599
	3,982
	1,2 17
	523 272
	13,096
	13,802
55,437	51,287




	;r ~
	16,747 1,432 1,374 1, 197 IOI 17 43 122 72 11 4 21,219 1,728 1,675 179 1,687 33,017 1,201 55,437 1,323 36,6 15 37,938 364 6,55 6 2, 103 1,355 5,808 607 16,793 17,499

	(Rs. in Lakhs)
Particulars	For the period ended September 30, 2024	For the period ended September 30, 2023
	Unaudited	Unaudited
A Cash Flow from operating activities
Profit before income tax	5,109	6,456
Adj ustments for
Add/(Less) :
Depreciation and amortisation expenses	1,oG0	844
Finance costs	32	17
Loss on disposal of property, plant and equipment	(5)	2
Unrealised exchange rate difference	(25)	(16)
Provision for Doubtful Debts and Advances (Net)	(56)	255
Interest received	(103)	(92)
Gain on sale of investments	(211)	( I 05)
Provisions no longer required and vvritten back	( 12)	-
Net fa ir va lue ga in on fin ancial assets mandatorily measured at fair va lue
through profit or loss	(75)	( 15 I)
	5,714	7,210
Working capital adjustments:
(Increase) in trade receivables	(3,649)	(2,503)
Decrease in fin ancial assets - Loans	2	-
(Increase) / Decrease in other financial assets	(76)	21
Decrease I (Increase) in other current assets	344	( 190)
Decrease / (In crease) in inventories	184	(552)
(Decrease) I Increase in trade payabl es	(169)	43 1
(Decrease) I Increase in other financial li abilities	(1,463)	30 1
Increase I (Decrease) in provisions	155	( 13)
Increase/ (Decrease) in other current liabilities	5,285	( I 03)
Cash generated from operations	6,327	4,602
Income taxes paid	(1,694)	(I, 178)
Net cash inflow from operating activities	4,633	3,424
B Cash flow from investing activities:
Acquisition of property, plant and equipment and Intangib le assets	(2,420)	(3, 136)
Proceeds from sale of property, pl ant and equipment	7	6
Movement in Other bank balances (Net)	-	3, 15 3
Investment in Mutual Funds	(2,150)	(3,550)
Receipt from Sale of Mutual fund	2,261	1,755
Interest received	103	92
Net cash ( outflow) from investing activities	(2, 199)	(1,680)
C Cash flow from financing activities
Proceeds from/ (Repayment of) long term borrowings	-	(I)
Interest paid	(32)	(8)
Dividend paid	(2,646)	(1,985)
Net cash (outflow) from financing activities	(2,678)	(1,994)
Net (decrease)/increase in cash and cash equivalents	(244)	(250)
Add: Cash and cash equivalents at the beginning of the financial period	1,972	2,482
Cash and cash equivalents at the end of the period	1,728	2,232

Unaudited statement of cash flows for the six months ended September 30, 2024

An :;R~ompany

Notes:

I. The above unaudited financia l results have been reviewed and recommended by the Audit Committee at its meeting held on November 6, 2024 and have been approved by the Board of Directors at its meetings held on November 7, 2024.
1. The Company operates in only one reportable business segment i.e. Pharmaceuticals.
1. Exceptional items for the quarter ended September 30, 2024 represents transfer charges of INR 2,730 lakhs paid by the Company, pursuant to the receipt of the order dated September 12, 2024 from Maharashtra Industrial Development Corporation (M IDC), Nav i Mumbai in response to the Company's application under amnesty scheme as per Government Resolution (GR) dated July 26, 2024 (as amended) in respect of levy of transfer charges towards assignment of portion of leasehold ri ghts made in earli er periods under the Urban Land (Ceiling and Regulation) Acl, 1976 .
1. Pursuant to the execution of a binding agreement dated September 13, 2024 with Mis KRSNA Dynasty, an unrelated party, for assignment of surplus vacant leasehold land along with built-up structures situated at M.LD.C. Navi Mumbai , the Company has reclassified non-current assets amounting to INR 1,20 1 lakhs forming part ofprope1ty, plant and eq uipment as non-current assets held for sale. The transaction is subject to satisfactory completion of the Conditions Precedent in the agreement and obtaining necessary approvals.